Affiliation:
1. School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, China
Abstract
Introduction:
Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of
nicotinamide with S-adenosine-L-methionine (SAM) as the methyl donor. Abnormal expression of
NNMT is associated with many diseases (such as multiple cancers and metabolic and liver diseases),
making NNMT a potential therapeutic target. Limited studies concerning the enzymesubstrate/
inhibitor interactions could be found to fully understand the detailed reaction mechanism.
Methods:
The binding affinity and ligand binding epitopes of nicotinamide or SAH for binding NNMT
and its mutants were determined using saturated transfer difference (STD) nuclear magnetic resonance
(NMR) techniques combined with site-directed mutagenesis.
Results:
The average dissociation constant of WT NNMT with nicotinamide and S-adenosine
homocysteine (SAH) was 5.5 ± 0.9 mM and 1.2 ± 0.3 mM, respectively, while the mutants Y20F and
Y20G with nicotinamide were up to nearly 4 times and 20 times that of WT and with SAH nearly 2
times and 5 times that of WT. The data suggested that WT had the highest binding affinity for
nicotinamide or SAH, followed by Y20F and Y20G, which was consistent with its catalytic activity.
Conclusion:
The binding affinity of nicotinamide and SAH to NNMT and its mutants were obtained
by STD NMR in this study. It was found that nicotinamide and SAH bind to WT in a particular
orientation, and Y20 is critical for their binding orientation and affinity to NNMT.
Funder
National Natural Science Foundation of China
Publisher
Bentham Science Publishers Ltd.
Subject
Biochemistry,General Medicine,Structural Biology